These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23287987)
1. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Kauppila JH; Mattila AE; Karttunen TJ; Salo T Br J Cancer; 2013 Feb; 108(3):638-43. PubMed ID: 23287987 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas. Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362 [TBL] [Abstract][Full Text] [Related]
3. FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma. Imayama N; Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Seki S; Fujita S; Ikeda T; Umeda M Pathol Oncol Res; 2015 Jul; 21(3):783-91. PubMed ID: 25573594 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue. Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738 [TBL] [Abstract][Full Text] [Related]
5. High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer. Zhou H; Chen JH; Hu J; Luo YZ; Li F; Xiao L; Zhong MZ J Cancer Res Clin Oncol; 2014 Apr; 140(4):633-43. PubMed ID: 24549739 [TBL] [Abstract][Full Text] [Related]
6. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study. Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335 [TBL] [Abstract][Full Text] [Related]
7. TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence. Haeggblom L; Näsman A; Ramqvist T; Haglund C; Hagström J; Mäkitie A; Dalianis T Acta Otolaryngol; 2019 Feb; 139(2):206-210. PubMed ID: 30794027 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of Helicobacter pylori without association of TLR5 expression in oral squamous cell carcinoma. Grimm M; Munz A; Exarchou A; Polligkeit J; Reinert S J Oral Pathol Med; 2014 Jan; 43(1):35-44. PubMed ID: 23659788 [TBL] [Abstract][Full Text] [Related]
9. For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Almangush A; Bello IO; Coletta RD; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kosma VM; Koivunen P; Kelner N; Kowalski LP; Grénman R; Leivo I; Läärä E; Salo T Virchows Arch; 2015 Jul; 467(1):39-46. PubMed ID: 25838076 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancer. Li H; Zhang Y; Chen SW; Li FJ; Zhuang SM; Wang LP; Zhang J; Song M Int J Clin Exp Pathol; 2014; 7(3):996-1003. PubMed ID: 24695539 [TBL] [Abstract][Full Text] [Related]
11. Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis. Ke ZF; He S; Li S; Luo D; Feng C; Zhou W Cancer Epidemiol; 2013 Apr; 37(2):179-85. PubMed ID: 23142337 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma. Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955 [TBL] [Abstract][Full Text] [Related]
14. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients. Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C Oncology; 2021; 99(12):790-801. PubMed ID: 34515203 [TBL] [Abstract][Full Text] [Related]
15. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma. Wen H; Chen Y; Hu Z; Mo Q; Tang J; Sun C Oncol Rep; 2014 Jan; 31(1):169-74. PubMed ID: 24252932 [TBL] [Abstract][Full Text] [Related]
16. Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival. Durr ML; van Zante A; Li D; Kezirian EJ; Wang SJ Otolaryngol Head Neck Surg; 2013 Jul; 149(1):89-96. PubMed ID: 23533221 [TBL] [Abstract][Full Text] [Related]
17. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028 [TBL] [Abstract][Full Text] [Related]